By Scientia Professor John Martin Kaldor

Journal articles

Collignon P; Dore GJ; Li Y; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates (multiple letters) [3]', Medical Journal of Australia, 169, pp. 444 - 448, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126845.x

Kippax S; Rosenthal D; Dowsett G; Kaldor J; Crofts N; McCallum L; Brotherton A, 1998, 'AIDS impact.', AIDS care, 10 Suppl 2

Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C - Summary vertical transmission rates may be misleading - Reply', BMJ-BRITISH MEDICAL JOURNAL, 316, pp. 554 - 554

Thomas S; Hall A; Newell ML; Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C (multiple letters) [5]', British Medical Journal, 316, pp. 553 - 554

Law MG; Downs AM; Brune JB; Kaldor JM, 1998, 'Time trends in HIV infection among pregnant women in Europe', AIDS, 12, pp. 211 - 216, http://dx.doi.org/10.1097/00002030-199802000-00012

Skov S; Tait P; Kaldor JM; Bowden FJ, 1998, 'A field trial of azithromycin in the treatment of donovanosis in Central Australia: a step towards eradiaction?', Venereology - the Interdisciplinary International Journal of Sexual Health, 11, pp. 11 - 14

Kaldor JM, 1998, 'AIDS in Asia and the Pacific Second edition', AIDS, 12

Cui JS; Kaldor JM, 1998, 'Changing pattern of delays in reporting AIDS diagnoses in Australia', Australian and New Zealand Journal of Public Health, pp. 432 - 435

Boffetta P; Fichtinger-Schepman AM; Weiderpass E; Van Dijk-Knijnenburg HC; Stoter G; Van Oosterom AT; Keizer HJ; Fossa SD; Kaldor JM; Roy P, 1998, 'Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients', Anti-Cancer Drugs, pp. 125 - 129

Kippax SC; Campbell DK; Van De Ven PG; Crawford G; Prestage G; Knox SJ; Culpin A; Kaldor JM; Kinder P, 1998, 'Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 10, pp. 677 - 688

Crofts JN; Dore GJ; Kaldor JM; Law MG; Wodak AD; Et A, 1998, 'Estimates and projections of the hepatitis C virus epidemic in Australia', ION Meeting Proceedings

Dore GJ; Brown TA; Tarantola D; Kaldor JM, 1998, 'HIV and AIDS in the Asia-Pacific region: an epidemiological overview', AIDS, 12, pp. S1 - S10

MacDonald MA; Sullivan PJ; Lock A; Wodak AD; Kaldor JM, 1998, 'HIV and HCV prevalence among fishing trawler crew', Australian and New Zealand Journal of Public Health, pp. 829 - 831

Thackway S; Furner V; Mijch AM; Cooper DA; Holland D; Martinez P; Shaw D; Van Beek IA; Wright E; Clezy KR; Kaldor JM, 1998, 'HIV infection in women in the Asia-Pacific region: the Australian experience', Journal of Hiv Therapy, pp. 9 - 12

Kaldor JM; Bharat S; Brown TA; Chan RC; Zhang K, 1998, 'HIV/AIDS in the Asia-Pacific region: the road remains long', AIDS, 12, pp. I - ii

Van Beek IA; Dwyer RG; Dore GJ; Luo K; Kaldor JM, 1998, 'Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study', British Medical Journal: International, pp. 433 - 437

Van Bentham BH; Veugelers PJ; Cornelisse PG; Strathdee S; Kaldor JM; Page-Shafer K; Coutinho RA; Van Griensven GJ, 1998, 'Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study', AIDS, 12, pp. 1039 - 1045

Dore GJ; Kaldor JM; Mccaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C', British Medical Journal: International, pp. 553 - 554

Ashton LJ; Carr AD; Cunningham PH; Roggensack M; Mclean K; Law MG; Robertson M; Cooper DA; Kaldor JM, 1998, 'Predictors of progression in long-term nonprogressors.', AIDS Research and Human Retroviruses, 14, pp. 117 - 121

Dowsett GW; Kaldor J; McInnes D; Spongberg M, 1998, 'Queer theory, politics and HIV/AIDS', Metascience, 7, pp. 444 - 465, http://dx.doi.org/10.1007/bf02910957

Kaldor JM, 1998, 'Review Symposia. Commentary on ¿Waldby C. AIDS and the body politic, biomedicine and sexual difference. London Routledge, 1996.¿', Metascience, pp. 448 - 472

Grulich A; Wan X; Law M; Milliken S; Lewis C; Garsia R; Gold J; Finlayson R; Cooper DA; Kaldor JM, 1998, 'RISK FACTORS FOR AIDS ASSOCIATED NON-HODGKIN'S LYMPHOMA: A CASE-CONTROL STUDY.', JAIDS Journal of Acquired Immune Deficiency Syndromes, 17, pp. a39, http://dx.doi.org/10.1097/00042560-199804010-00127

Dore GJ; Kaldor JM, 1998, 'Sexually transmissible diseases surveillance in Australia: towards a coordinated national system', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, pp. 49 - 52

Dore GJ; Li YW; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality in Australia, 1979-1994', Medical Journal of Australia, 168, pp. 601 - 604

Dore GJ; Li YW; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates', Medical Journal of Australia, 169, pp. 444 - 445

Aguado JM; Pulido F; Dore GJ; Law MG; Kaldor JM; Gordin F; Matts J, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection [4] (multiple letters)', New England Journal of Medicine, 337, pp. 1696 - 1697, http://dx.doi.org/10.1056/NEJM199712043372316

Dore GJ; Law MG; Kaldor JM, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.', New England Journal of Medicine, 337, pp. 1697

Law MG; Kaldor JM, 1997, 'Survival analysis of randomized clinical trials adjusted for patients who switch treatments - Reply', STATISTICS IN MEDICINE, 16, pp. 2620 - 2621, http://dx.doi.org/10.1002/(SICI)1097-0258(19971130)16:22<2620::AID-SIM1699>3.0.CO;2-4

Porter K; Law MG; Kaldor JM; Lepri AC; Phillips AN; Pezzotti P; Rezza G; Sinicco A; Fora R; Raiteri R; Sciandra M; Bechis G; Calvo MM; Gioannini P, 1997, 'Is the clinical course of HIV infection changing?', BMJ, 315, pp. 1236, http://dx.doi.org/10.1136/bmj.315.7117.1236a

Law MG; Kaldor JM, 1997, 'Is the clinical course of HIV infection changing? Exclusion of people not followed up for 12 months may have biased results.', BMJ (Clinical research ed.), 315, pp. 1236 - 1237

MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.', Med J Aust, 166, pp. 237 - 240, https://www.ncbi.nlm.nih.gov/pubmed/9076266

Law MG; Kaldor JM, 1997, 'A note on the grouping of surveillance data when adjusting for reporting delays', American Journal of Epidemiology, 146, pp. 592 - 595, http://dx.doi.org/10.1093/oxfordjournals.aje.a009319

Harris PJ; Russo IH; Grulich AE; Kaldor JM; Gill PS; Lunardi- Iskandar Y; Gallo RC; Krown SE; Rabkin CS, 1997, 'Intralesional human chorionic gonadotropin for Kaposi's sarcoma [2] (multiple letters)', Journal of Materials Science Materials in Medicine, 8, pp. 1187 - 1189

McNulty A; Rowbottom J; Kaldor J, 1997, 'Sentinel sexually transmitted diseases surveillance at sexual health clinics', Venereology, 10, pp. 11 - 13

Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM, 1997, '"HIV-1 Infection among Female Commercial Sex Workers in Rural Thailand."', Studies in Family Planning, 28, pp. 168 - 168, http://dx.doi.org/10.2307/2138125

Dore GJ; Law MG; Kaldor JM, 1997, 'A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis', New England Journal of Medicine, pp. 315 - 320

Veugelers PJ; Strathdee S; Kaldor JM; Page-Shafer K; Moss AR; Schechter MT; Coutinho RA; Keet IP; Van Griensven GJ, 1997, 'Association of age, immunosuppression and AIDS among homosexual men in the Tricontinental Seroconverter Study', Journal of acquired immune deficiency syndrome and human retrovirology, 14, pp. 435 - 441

Hurley SF; Jolley D; Kaldor JM, 1997, 'Effectiveness of needle-exchange programmes for prevention of HIV infection', Lancet, pp. 1797 - 1800

Crofts N; Jolley D; Kaldor JM; Van Beek IA; Wodak AD, 1997, 'Epidemiology of hepatitis C virus infection among injecting drug users in Australia', Journal of Epidemiology and Community Health, 51, pp. 692 - 697

Thackway S; Furner V; Mijch AM; Cooper DA; Holland D; Martinez P; Shaw D; Van Beek IA; Wright E; Clezy KR; Kaldor JM, 1997, 'Fertility and reproductive choice in women with HIV-1 infection', AIDS, 11, pp. 663 - 667

Kaldor JM, 1997, 'Hepatitis B incidence in Australia', Vaccine news, pp. 1 - 2

MacDonald MA; Kaldor JM, 1997, 'Hepatitis C: epidemiology', Australian Chinese Medical Association Journal, 2

Mcnulty A; Li Y; Radtke U; Kaldor JM; Rohrsheim R; Cooper DA; Donovan BJ, 1997, 'Herpes zoster and the stage and prognosis of HIV-1 infection', Genitourinary Medicine, pp. 467 - 470

MacDonald MA; Wodak AD; Ali RL; Crofts N; Cunningham PH; Dolan K; Kelaher M; Loxley W; Van Beek IA; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in need exchange attenders: a natinoal study', Medical Journal of Australia, 166, pp. 237 - 240

Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM, 1997, 'HIV-1 infection among female commercial sex workers in rural Thailand', AIDS, 11, pp. 89 - 94

Kaldor JM, 1997, 'HTLV-1 and blood safety: let the community decide', Medical Journal of Australia, 166, pp. 454 - 455

Veugelers PJ; Kaldor JM; Strathdee S; Page-Shafer K; Schechter MT; Coutinho RA; Keet IP; Van Griensven GJ, 1997, 'Incidence and prognostic significance of symptomatic primary immunodeficiency virus type 1 infection in homosexual men', Journal of Infectious Diseases, 176, pp. 112 - 117

Stewart GJ; Ashton LJ; Biti RA; Ffrench RA; Bennetts BH; Newcombe NR; Benson EM; Carr A; Cooper DA; Kaldor JM; Anderson B; Allworth A; Ashton L; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth N; Carr A; Clare K; Cooper D; Cummins E; Cunningham P; Couldwell D; Deacon N; Doong N; Finlayson R; Ffrench R; Furner V; Huffam S; Kaldor J; Kidd J; Kelly M; Lloyd A; McFarlane R; McLean K; McNulty A; McPhee D; Michelmore H; McMurchic M; Mutimer K; Peterson J; Price R; Quan D; Quin J; Ree H; Robertson M; Roggensack M; Schroeder K; Smith D; Spencer D; Stewart G; Sullivan J; Ziegler J, 1997, 'Increased frequency of CCR-5 Delta 32 heterozygotes among long-term non-progressors with HIV-1 infection', AIDS, 11, pp. 1833 - 1838, http://dx.doi.org/10.1097/00002030-199715000-00007

Grulich AE; Kaldor JM, 1997, 'Intralesional human chorionic gonadotropin for Kaposi`s sarcoma', New England Journal of Medicine, pp. 1187 - 1188

Van Bentham BH; Veugelers PJ; Schechter MT; Kaldor JM; Page-Shafer K; Van Griensven GJ, 1997, 'Modelling the AIDS incubation time: evaluation of three right censoring strategies', AIDS, 11, pp. 834 - 835

Back to profile page